VOVictor V. Osovskikh

Victor V. Osovskikh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Victor V. Osovskikh has a total of 44 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Use of infrared fluorescence graft angiography for intraoperative assessment of blood flow: Experience with the Russian-made MARS system

    by E. L. Zaslavskaya, V. V. Osovskikh, D. G. Gramatikov, V. S. Litus, E. A. Polyakova, Е. Л. Заславская, В. В. Осовских, Д. Г. Граматиков, В. С. Литус, Е. А. Полякова

    Introduction. Near-infrared fluorescent graft angiography with indocyanine green enables intraoperative assessment of mammary and venous graft patency in patients with coronary artery disease (CAD). Materials and methods . The study included 26 patients: some had stable forms of CAD (n = 19), and some had acute coronary syndrome (ACS, n = 7). All patients had indications for mammary-coronary and aorto-coronary bypass grafting. Surgery was performed on the beating heart using an Octopus vacuum stabilizer. To assess graft patency, near-infrared fluorescent imaging was used with the contrast agent indocyanine green and the MARS system. Intraoperative visualization of blood flow was obtained for all grafts, including mammary-coronary and autovenous grafts. Performance and interpretation of each angiographic series took approximately 2–3 minutes; repeat examination was required in 2 patients. In most cases, the quality of angiograms and histograms recorded during surgery was good and comparable to conventional coronary angiography. Results. This method was applied in all patients. No adverse events associated with the dye were observed during or after the examination. Adequate intraoperative visualization was obtained in 26 patients (26 video recordings). The visualization quality allowed reliable assessment of coronary graft patency and myocardial perfusion. A non-functioning graft was detected in three patients (11,5%); in two of them (2 of 58 grafts, 3,4%; 2 of 26 patients, 7,7%) intraoperative anastomotic revision was performed, followed by repeat fluorescent graft angiography that confirmed restoration of blood flow. Conclusions . Near-infrared fluorescent graft angiography with indocyanine green is a useful and safe technique. It enables rapid assessment of coronary bypass grafts without side effects or complications and allows timely detection of technical anastomotic defects, which may potentially reduce the risk of type 5 myocardial infarction and improve treatment outcomes in patients with coronary artery disease. The impact of the technique on early postoperative mortality requires confirmation in comparative studies.

  • Open Access

    Nitric oxide delivery into oxygenators of artificial and assisted blood circulation. Current state and prospects of technology development (literature review)

    by E. K. Barygin, A. O. Marichev, A. M. Radovskiy, V. V. Osovskikh, K. Yu. Afanasyeva, D. A. Kozyrev, I. G. Chomahashvili, G. N. Ablesimov, V. V. Pichugin, S. E. Domnin, et al.

    The use of cardiopulmonary bypass (CPB) technologies is often associated with ischemic and re-perfusion injury to the myocardium. The contact of patient’s blood with the surface of the extracorporeal circuit leads to platelets activation and often triggers a systemic inflammatory reaction. Nitric oxide (NO) is a signal molecule produced by the endothelium of blood vessels. Under normal circumstances, it prevents excessive activation and aggregation of platelets, thus providing an organ-protective effect. Currently, there is a considerable amount of data available about positive effects of use of inhaled NO. Nitric oxide delivery into oxygenators of artificial and assisted blood circulation. However, there is a limited amount of publications on effects of NO delivery into gas circuit of oxygenators of artificial and assisted blood circulation. The objective of this article was to summarize currently available information about effects of NO delivery into extracorporeal circuits oxygenators through extensive literature review.


  • Open Access

    The effect of nitric oxide supplied to the oxygenator of the cardiopulmonary bypass on the functions and morphology of internal organs: experimental animal study

    by A. E. Bautin, A. M. Radovskiy, A. O. Marichev, V. V. Osovskikh, N. Y. Semenova, Z. E. Artyukhina, S. E. Voronin, L. A. Murashov, N. A. Kotin, V. A. Zinserling

    To evaluate the effect of NO added to the oxygenator during CPB on the liver and kidneys in pigs.Methods. The experiment was conducted on 10 pigs undergoing cardiac surgery using cardiopulmonary bypass (CPB). Animals of the experimental group (CPB-NO; n = 5) received NO with the gas mixture supplied to the oxygenator at 100 ppm. Animals of the control group (CPB-control; n = 5) did not receive NO via the oxygenator. The surgery lasted 4 hours and was followed by 12-hour postoperative monitoring. To assess the liver and kidney injury, the levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), bilirubin, creatinine, neutrophil gelatinase-associated lipocalin (NGAL) were determined at baseline, at weaning from the CPB, 6 and 12 hours after weaning from the CPB. A pathomorphological study of the liver and kidneys was also performed.Results. A long period of CPB deliberately used in our experiment caused liver injury. In the CPB-control group, an increase in the ALT concentration was found: 43 (34; 44) U/l at baseline to 82 (53; 99) U/l 12 hours after CPB, p < 0.05. AST concentration in the CPB-control group increased from 25 (17; 26) U/l at baseline to 269 (164; 376) U/l 12 hours after CPB (p < 0.05). We found no significant increase in ALT and AST concentrations in the CPB-NO group. There were no significant differences in ALT and AST concentrations between CPB-NO and CPB-control groups at all study time points. In the CPB-control group, an increase in the creatinine level was found from 131 (129; 133) μmol/l at baseline to 273 (241; 306) μmol/l 12 hours after CPB (p < 0.05). We found no significant increase in creatinine levels in the CPB-NO group. Creatinine levels in the CPB-NO group were significantly lower than in the CPB-control group 12 h after weaning from CPB: 183 (168; 196) vs 273 (241; 306) μmol/l (p < 0.008). We found no significant differences between the study groups by the NGAL level. Morphology revealed characteristic alterative changes in tissues, circulatory disorders, and inflammatory infiltration of varying degrees of severity, which in combination is a manifestation of the acute damaging effect of CPB. In the CPB-NO group, the severity of pathological changes, measured in points, was lower than in the CPB-control group, but no statistically significant differences were found.Conclusion. NO added to the oxygenator gas mixture reduces liver and kidney injury during prolonged CPB. Further research is required.


  • Analysis of indocyanine green plasma disappearance rate in clinical practice

    by V.V. Osovskikh, L.N. Kiseleva, I.N. Kolokolnikov, M.S. Vasilieva, A.E. Bautin

    OBJECTIVE To justify the optimal method for determining indocyanine green plasma disappearance rate (PDRICG). MATERIAL AND METHODS We analyzed PDRICG in intensive care units. Indocyanine green was administered intravenously at a dose of 0.25 mg/kg. PDRICG was analyzed simultaneously by using of three methods: 1) PDD (PiCCO2 LiMON device), 2) SBS with analysis of plasma samples on precise spectrophotometer, 3) SBS with analysis of plasma samples on simple experimental photometer. RESULTS PDD method was used for 346 PDRICG tests in 256 patients. Of these, 14.3% of measurements were erroneous. Paired tests using PDD and SBS methods were performed in 299 cases. SBS method resulted erroneous data in 0.6% of cases. Certain correlation (r=0.79, pICG of the PDD method (for example, more than 30%/min). Comparison of two SBS variants (spectrophotometer and experimental photometer) revealed good correlation (r=0.91, pICG ensures accurate results under mechanical interferences in patients with impaired capillary blood flow. This eliminates the need for redo measurement. Duplication of the PDD and SBS methods is recommended when repeating the test is not possible (organ donors).


  • Open Access

    Factors that determine cell-free hemoglobin concentration in blood prime during cardiac surgery with cardiopulmonary bypass: a prospective observational study

    by Андрей Евгеньевич Баутин, A. O. Marichev, L. I. Karpova, A. M. Radovskiy, E. K. Barygin, A. K. Gusenova, N. V. Blokhina, V. V. Osovskikh, G. N. Ablesimov, V. K. Grebennik, et al.

    INTRODUCTION: Plasma cell-free hemoglobin (Hbf) has a negative effect on the results of cardiac surgery. OBJECTIVE: Analysis of the dynamics of the Hbf during cardiosurgical operations with CPB. Identification of the main factors for increasing the Hbf. MATERIALS AND METHODS: A prospective, single-center, cohort study included 50 patients who underwent cardiac surgery with CPB. Hbf was monitored before surgery, during CPB (10 minutes after the start, then every 30 minutes) and every 6 hours for two days. RESULTS: An increase in Hbf levels was found in 90 % of surgical procedure. In 8 % of cases, hemolysis was mild (0.1 < Hbf ≤ 0.4 g/l), in 48 % — moderate (0.4 < Hbf < 1 g/l), severe (Hbf ≥ 1 g/l) was after 34 % of operations. After weaning from CPB Hbf rapidly decreases and after 12 hours drop to the preoperative level. Aortic cross-clamping is a risk factor with an odds ratio of 1.038 (p = 0.036). A positive correlation was established between the Hbf level and the duration of CPB (r = 0.76; p < 0.001). In ROC-analysis, a good predictive ability for development of severe hemolysis was demonstrated by the time of CPB: AUC 0.74 (p = 0.014) with a threshold value of 76 minutes. During CABG, severe hemolysis developed significantly less frequently than during valve corrections — 12.5 % versus 44.1 %, p = 0.026. Hbf content was significantly lower with an initial hemoglobin concentration < 140 g/l than in patients with an initial hemoglobin level ≥ 140 g/l — 0.7 (0.5; 0.95) g/l versus 0.9 (0.7; 1.28) g/l, p = 0.036. CONCLUSIONS: Hemolysis is typical for the cardiac surgeries with CPB. The time of aoral clamping and CPB, the type of surgcry, the hemoglobin content before surgcry have an impact on the severity of hemolysis.


  • Perioperative management of patients with concomitant liver diseases. Guidelines

    by I.B. Zabolotskikh, E.G. Gromova, A.N. Kuzovlev, K.M. Lebedinskii, A.YU. Lubnin, V.V. Osovskikh, S.V. Sinkov, S.E. Horoshilov, R.V. Shadrin, A.V. Shchegolev

    В настоящее время частота заболеваний печени и желчевыводящей системы неуклонно растет, что делает проблему все более актуальной. Причины исходной патологии печени, предрасполагающие к развитию печеночной недостаточности, многообразны — острые и хронические вирусные гепатиты, медикаментозное поражение гепатотоксическими препаратами, употребление алкоголя и наркотиков, другие инфекционные и паразитарные заболевания, системные и онкологические заболевания и др. В клинических рекомендациях представлены особенности предоперационного осмотра и подготовки пациентов с сопутствующими заболеваниями печени. Обсуждается влияние анестетиков на функцию печени и влияние печеночной дисфункции на фармакокинетику препаратов. Рассмотрены осложнения, возникающие в послеоперационном периоде у пациентов с сопутствующими заболеваниями печени (печеночная энцефалопатия, асцит и спонтанный бактериальный перитонит, гепаторенальный синдром, кровотечение из варикозно расширенных вен пищевода, дилюционная гипонатриемия, печеночная коагулопатия). В основу статьи положены современные рекомендации Европейской ассоциации по изучению печени (European Association for the Study of the Liver, EASL), Американской ассоциации по изучению болезней печени (American Association for the Study of Liver Diseases, AASLD), Европейского общества анестезиологов (ESA), Российского общества хирургов, Российского общества по изучению печени, а также соответствующие литературные первоисточники.


  • Infrared Finger-Piece Sensor for ICG Concentration Measurements

    by Ilya Kolokolnikov, Elena Velichko, Lyubov Kiseleva, Victor Osovskikh

  • Open Access

    Prognostic value of selected hypercoagulability markers in sepsis. A prospective study

    by Victor V. Osovskikh, M. S. Vasileva, A. E. Bautin, L. N. Kiseleva

    Introduction. Sepsis is a heterogeneous syndrome caused by an unbalanced host response to an infection, resulting in organ dysfunction. Disseminated intravascular coagulation (DIC) varies widely from 30 % to 60 % and depends on different scoring systems. An overt DIC easily identified, while the pre-existing phase of hypercoagulability can’t be detected by screening coagulation tests. Preventive DIC treatment is hardly possible without an early diagnostics. Objectives. The aim of the study is identifying the hypercoagulabiliy markers in septic patients with hypercoagulability pattern on thromboelastometry (TEM) and matching them to the outcome. Materiasl and methods. ROTEM screening of septic patients revealed 85 ones with pattern of hypercoagulability. Thrombin generation test with thrombomodulin, screening coagulation tests, anticoagulants levels and selected hypercoagulability markers were performed from frozen plasma samples. According to the outcome patients were divided to survivors and nonsurvivors. Results. The survivors group included 62 patients and nonsurvivors — 19. Thrombin generation test revealed only 7 cases of hypercoagulability. There was no significant difference in endogenous thrombin potential 20 (10; 25) % vs 14 (10; 31) % and peak thrombin 8 (2,9; 16) % vs 7 (3; 18) % in survivors and nonsurvivors, respectively. Other significant differences between survivors vs nonsurvivors are: protein C 79,5 ± 28 % vs 64,9 ± 25 %, FVIII 226,4 ± 66 % vs 276,6 ± 94 % , von Willebrand factor 269 ± 129 % vs 435 ± 181 %, Аntithrombin 82 (60; 94) % vs 65 (41; 80) %, and D-dimer 2157 (1341; 3964) mcg/l vs 3253 (1911; 6914) mcg/l, respectively. Conclusion. Septic patients with TEM criteria of hypercoagulability may have unique set of thrombophilia markers. Local screening coagulation tests do not affect the prognosis. Low level of protein C and antithrombin, as well as high FVIII, von Willebrand factor, D-dimer worsen outcome.